In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Genome Therapeutics acquires GeneSoft Pharmaceuticals

Executive Summary

Genome Therapeutics (GT) is acquiring fellow anti-infective therapeutics developer GeneSoft Pharmaceuticals for about $106mm. It issued GeneSoft 28mm of its shares, worth $82mm just prior to announcement, plus assumed $24mm of GeneSoft's debt. GT will own 57% of the combined company.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Includes Contract
    • Intra-Biotech Deal
    • Partial Acquisition
    • Payment Includes Stock

Related Companies